Peptide Profiles — 2026-04-11
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that has been extensively studied for its ability to increase growth hormone (GH) secretion. Available in two forms — with and without Drug Affinity Complex (DAC) — each version offers distinct pharmacokinetic properties for different research applications.
The DAC modification extends the half-life dramatically by binding to albumin in the bloodstream.
Without the DAC modification, this peptide more closely mimics natural GHRH signaling.
One of the most studied peptide combinations is CJC-1295 (no DAC) with ipamorelin. The rationale: - CJC-1295 stimulates the GHRH pathway (amplifies the signal) - Ipamorelin stimulates the ghrelin/GHSR pathway (initiates the pulse) - Together, they produce a synergistic increase in GH release
Growth hormone plays a central role in: - Body composition regulation - Bone density maintenance - Metabolic health - Recovery and tissue repair - Sleep quality and patterns
Understanding GH secretagogues like CJC-1295 is essential for researchers studying these interconnected systems.
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.